BRISTOL-MYERS SQUIBB HOLDINGS IRELAND has a total of 28 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Hungary, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are ABBVIE SARL, TELIGENE LTD and CRYSTALGENOMICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Hungary | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Japan | 3 | |
#4 | EAPO (Eurasian Patent Organization) | 2 | |
#5 | Israel | 2 | |
#6 | Peru | 2 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Lithuania | 1 | |
#11 | Netherlands | 1 | |
#12 | Slovenia | 1 | |
#13 | Taiwan | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Packaging and shipping | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Romine Jeffrey Lee | 4 |
#2 | Lopez Omar D | 4 |
#3 | Martel Alain | 4 |
#4 | Lavoie Rico | 4 |
#5 | St Laurent Denis R | 4 |
#6 | Yang Fukang | 4 |
#7 | Belema Makonen | 4 |
#8 | Langley David R | 4 |
#9 | Wang Gan | 4 |
#10 | Nguyen Van N | 4 |
Publication | Filing date | Title |
---|---|---|
HUS1500008I1 | Hepatitis c virus inhibitors | |
HUE025090T2 | Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide | |
HUE026040T2 | Formulations of a src/abl inhibitor |